SCHEMBL31694534

SCHEMBL31694534

CC(C)Oc1ccc(-c2ncc(CNc3cc(C#N)nc(-c4cn[nH]c4)c3)s2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ CYP2C9 P11712 1/20 0.40
▸ SCN9A Q15858 2/20 0.34
▸ S1PR1 P21453 2/20 0.34
▸ PTGDR Q13258 1/20 0.34
▸ NAMPT P43490 2/20 0.33
▸ HDAC3 O15379 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.32
▸ S1PR5 Q9H228 1/20 0.32
▸ PCSK9 Q8NBP7 1/20 0.32
▸ SCN2A Q99250 1/20 0.32
▸ SCN10A Q9Y5Y9 1/20 0.32
▸ MAPK8 P45983 1/20 0.31
▸ ROCK2 O75116 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23627693 0.89 CYP2C19 (0.43) CYP2C19KCNH2CYP2C9S1PR1PTGDR
SCHEMBL30060450 0.85 CYP2C19 (0.52) CYP2C19KCNH2CYP2C9S1PR1PTGDR
SCHEMBL23611535 0.85 CYP2C19 (0.52) CYP2C19KCNH2CYP2C9S1PR1PTGDR
SCHEMBL21614697 0.81 CYP2C19 (0.55) CYP2C19KCNH2CYP2C9S1PR1HDAC3
SCHEMBL23611318 0.79 CYP2C19 (0.51) CYP2C19KCNH2CYP2C9S1PR1HDAC3
SCHEMBL30062257 0.79 CYP2C19 (0.51) CYP2C19KCNH2CYP2C9S1PR1HDAC3
SCHEMBL21614696 0.76 CYP2C19 (0.54) CYP2C19KCNH2CYP2C9S1PR1HDAC3
SCHEMBL23611317 0.72 CYP2C19 (0.52) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL30060458 0.72 CYP2C19 (0.52) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL21614737 0.71 CYP2C19 (0.73) CYP2C19KCNH2CYP2C9S1PR1S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-B1 PYRIDINE AND PYRIMIDINE DERIVATIVES USEFUL AS PQSR INVERSE AGONISTS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-10-08 — — EP disclosed
Send feedback